Search

Search Constraints

You searched for: Author/Creator Vakeva, L.

Search Results

1. A study of quality of life in people with mycosis fungoides and Sézary syndrome. (1st March 2020)

2. A study of quality of life in people with mycosis fungoides and Sézary syndrome. (28th February 2020)

3. An overall response in skin is associated with improved HRQoL in patients with MF/SS enrolled in the PROCLIPI study. (2019)

4. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. (1st March 2020)

5. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. (28th July 2019)

6. Should we be imaging lymph nodes at initial diagnosis of early‐stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study*. (1st March 2021)

7. Should we be imaging lymph nodes at initial diagnosis of early‐stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study. (10th September 2020)

8. Should we be imaging lymph nodes at initial diagnosis of early‐stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study. (1st March 2021)

9. T-cell receptor rearrangements in the skin and blood of patients in the PROCLIPI study: detection of clonal rearrangements in the skin (and blood) correlates with the B-class of MF and SS patients. (2019)

10. The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients. (1st August 2019)